No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

HomeEXECUTIVES

Category: EXECUTIVES

Avation Medical adds Vice President...

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Xeno Biosciences Welcomes New CEO,...

Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.

Avation Medical adds Vice President of Market Access

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

John Witkowski Appointed President & CEO of Solesis

John Witkowski served as President of DSM Biomedical, the global biomaterials division of dsm-firmenich, where he led a significant period of transformational growth.

Julia James Appointed Clario Chief Legal and Administrative Officer

Julia James served as Executive Vice President and General Counsel of PPD, the leading contract research organization, until its acquisition by Thermo Fisher Scientific in 2021. She then continued as General Counsel, Clinical Research, following the transaction.

John Edwards Appointed PanTher Therapeutics Executive Chair of the Board of Directors

John Edwards brings over 35 years of experience in discovery, development, and global commercialization of biopharmaceuticals to PanTher. His experience includes involvement with ten FDA approved biologics and eight biotech companies with successful exits, including Tilos Therapeutics, Siamab, Adnexus, F-star and Genetics Institute.

Lori Shoaf Joins AAOS as Vice President of the Office of Govenment Relations

Lori Shoaf spent a decade as the executive director of partnerships, advocacy and coalitions at the Blue Cross Blue Shie Association. She also has previous federal government relations experience at several member healthcare associations.

RIVANNA® Welcomes Craig Loomis to Drive Product Excellence

Will Mauldin, PhD, RIVANNA co-founder and CEO on the appointment of Craig Loomis, "Craig's proven track record in driving revenue growth, launching innovative products and cultivating customer relationships will be pivotal in driving the successful adoption of Accuro 3S within the acute pain neuraxial market and its adjacent indications, which collectively represent a total addressable market exceeding $1 billion."

Unveiling a Visionary Leader: Dr A Burton Tripathi Assumes CEO Role at Beyeonics

Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.

John Taylor Appointed Head of Quality & Compliance Practice at ELIQUENT Life Sciences

John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.

Jennifer Riter Appointed VP of Analytical Services at Kindeva Drug Delivery

Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.

Christine Senn, PhD Appointed Senior Vice President, Head of Site-Sponsor Innovation at Advarra

Chistine Senn will serve as Chair of the Site-Sponsor Consortium – a collaborative body now in its second year – and as Chair of Advarra's Customer Advisory Board. She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra's mission.

By using this website you agree to accept Medical Device News Magazine Privacy Policy